par Jacobs, Frédérique
;Selleslag, Dominik;Aoun, Michel
;Sonet, Alexis
;Gadisseur, A
Référence European journal of clinical microbiology & infectious diseases, 31, 6, page (1173-1179)
Publication Publié, 2012-06
;Selleslag, Dominik;Aoun, Michel
;Sonet, Alexis
;Gadisseur, ARéférence European journal of clinical microbiology & infectious diseases, 31, 6, page (1173-1179)
Publication Publié, 2012-06
Article révisé par les pairs
| Titre: |
|
| Auteur: | Jacobs, Frédérique; Selleslag, Dominik; Aoun, Michel; Sonet, Alexis; Gadisseur, A |
| Informations sur la publication: | European journal of clinical microbiology & infectious diseases, 31, 6, page (1173-1179) |
| Statut de publication: | Publié, 2012-06 |
| Sujet CREF: | Cancérologie |
| MeSH keywords: | Adolescent |
| Adult | |
| Aged | |
| Aged, 80 and over | |
| Antifungal Agents -- administration & dosage -- adverse effects | |
| Aspergillosis -- drug therapy -- mortality | |
| Drug Toxicity -- epidemiology | |
| Female | |
| Humans | |
| Male | |
| Middle Aged | |
| Prospective Studies | |
| Pyrimidines -- administration & dosage -- adverse effects | |
| Survival Analysis | |
| Time Factors | |
| Treatment Outcome | |
| Triazoles -- administration & dosage -- adverse effects | |
| Young Adult | |
| Note générale: | Journal Article |
| Multicenter Study | |
| Research Support, Non-U.S. Gov't | |
| SCOPUS: ar.j | |
| Langue: | Anglais |
| Identificateurs: | urn:issn:0934-9723 |
| info:doi/10.1007/s10096-011-1425-5 | |
| info:scp/84863846189 | |
| info:pmid/21971820 | |
| PMC3346940 |



